These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2006-000413-37||trastuzumab, docetaxel and oxaliplatino association in metastatic breast cancer with her2 receptor overexepression Phase II clinical trial||not-yet-due|
|Not reported Terminated||2009-016653-17||TREATMENT OF HYPOTENSION IN EXTREMELY PRETERM INFANTS: A MULTICENTER RANDOMIZED CONTROLLED TRIAL||2013-04-29||due-trials|
|Ongoing||2010-018718-57||Role of on-line hemodiafiltration (HDF) in the modulation of resistance to erythropoiesis stimulating agents (REDERT)||not-yet-due|
|Ongoing||2010-018762-23||METRONOMIC ORAL VINORELBINE IN ADVANCED (STAGE IIIB-IV) NON-SMALL CELL LUNG CANCER PATIENTS: A PHASE II TRIAL (MOVE Trial � ASL1209/001)||not-yet-due|